Folgen
Barbora Malecova
Barbora Malecova
Sanford Burnham Prebys Medical Discovery Institute
Bestätigte E-Mail-Adresse bei sbpdiscovery.org
Titel
Zitiert von
Zitiert von
Jahr
STAT3 signaling controls satellite cell expansion and skeletal muscle repair
MT Tierney, T Aydogdu, D Sala, B Malecova, S Gatto, PL Puri, L Latella, ...
Nature medicine 20 (10), 1182-1186, 2014
3822014
Signal‐dependent incorporation of MyoD–BAF60c into Brg1‐based SWI/SNF chromatin‐remodelling complex
SV Forcales, S Albini, L Giordani, B Malecova, L Cignolo, A Chernov, ...
The EMBO journal 31 (2), 301-316, 2012
2242012
Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy
B Malecova, S Gatto, U Etxaniz, M Passafaro, A Cortez, C Nicoletti, ...
Nature communications 9 (1), 3670, 2018
1652018
Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres
S Albini, P Coutinho, B Malecova, L Giordani, A Savchenko, SV Forcales, ...
Cell reports 3 (3), 661-670, 2013
1402013
Transcriptional gene silencing mediated by non-coding RNAs
B Malecová, KV Morris
Current opinion in molecular therapeutics 12 (2), 214, 2010
1292010
Nuclear export determines the cytokine sensitivity of STAT transcription factors
I Lödige, A Marg, B Wiesner, B Malecová, T Oelgeschläger, ...
Journal of Biological Chemistry 280 (52), 43087-43099, 2005
722005
Honeybee (Apis mellifera L.) mrjp gene family: computational analysis of putative promoters and genomic structure of mrjp1, the gene coding for the most abundant protein of …
B Malecová, J Ramser, JK O'Brien, M Janitz, J Júdová, H Lehrach, ...
Gene 303, 165-175, 2003
602003
Brahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesis
S Albini, P Coutinho Toto, A Dall'Agnese, B Malecova, C Cenciarelli, ...
EMBO reports 16 (8), 1037-1050, 2015
432015
DEFOG: A practical scheme for deciphering families of genes
T Fuchs, B Malecova, C Linhart, R Sharan, M Khen, R Herwig, ...
Genomics 80 (3), 295-302, 2002
362002
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...
US Patent 11,246,941, 2022
322022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...
US Patent 10,881,743, 2021
282021
TBP/TFIID-dependent activation of MyoD target genes in skeletal muscle cells
B Malecova, A Dall'Agnese, L Madaro, S Gatto, P Coutinho Toto, S Albini, ...
Elife 5, e12534, 2016
272016
The initiator core promoter element antagonizes repression of TATA-directed transcription by negative cofactor NC2
B Malecová, P Gross, M Boyer-Guittaut, S Yavuz, T Oelgeschläger
Journal of Biological Chemistry 282 (34), 24767-24776, 2007
272007
TFIIB recognition elements control the TFIIA-NC2 axis in transcriptional regulation
W Deng, B Malecová, T Oelgeschläger, SGE Roberts
Molecular and cellular biology 29 (6), 1389-1400, 2009
252009
Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)
B Malecova, RS Burke, M Cochran, MD Hood, R Johns, PR Kovach, ...
Nucleic Acids Research 51 (12), 5901-5910, 2023
222023
Myosin phosphatase modulates the cardiac cell fate by regulating the subcellular localization of Nkx2. 5 in a Wnt/Rho–associated protein kinase–dependent pathway
T Ryan, M Shelton, JP Lambert, B Malecova, S Boisvenue, M Ruel, ...
Circulation research 112 (2), 257-266, 2013
222013
“Mix of mics”-phenotypic and biological heterogeneity of “multipotent” muscle interstitial cells (MICs)
B Malecova, PL Puri
Journal of stem cell research & therapy, 2012
202012
Nucleic acid-polypeptide compositions and uses thereof
AJ Geall, VR Doppalapudi, JD Arias, DS Chu, MC Cochran, R Burke, ...
US Patent 11,110,180, 2021
132021
Muscle-relevant genes marked by stable H3K4me2/3 profiles and enriched MyoD binding during myogenic differentiation
H Cui, V Bansal, M Grunert, B Malecova, A Dall'Agnese, L Latella, S Gatto, ...
PloS one 12 (6), e0179464, 2017
132017
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...
US Patent 11,253,607, 2022
112022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20